PTCT icon

PTC Therapeutics

282 hedge funds and large institutions have $3.9B invested in PTC Therapeutics in 2025 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 111 increasing their positions, 80 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.96% more ownership

Funds ownership: 99.87%100.83% (+0.96%)

3% less capital invested

Capital invested by funds: $4.02B → $3.9B (-$121M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
282
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.1M
Puts
$7.7M
Net Calls
Net Calls Change

Top Sellers

1 -$76.4M
2 -$70M
3 -$34.4M
4
AC
Armistice Capital
New York
-$33.2M
5
UBS Group
UBS Group
Switzerland
-$32.8M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$284K
202
$284K
203
$281K
204
$280K
205
$258K
206
$254K
207
$244K
208
$241K
209
$238K
210
$229K
211
$226K
212
$222K
213
$222K
214
$217K
215
$205K
216
$204K
217
$186K
218
$175K
219
$155K
220
$150K
221
$129K
222
$129K
223
$121K
224
$115K
225
$96.4K